Q5EBN2
Gene name |
TRIM61 (RNF35) |
Protein name |
Putative tripartite motif-containing protein 61 |
Names |
RING finger protein 35 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:391712 |
EC number |
|
Protein Class |
|

Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q5EBN2
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q5EBN2-F1 | Predicted | AlphaFoldDB |
163 variants for Q5EBN2
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
TCGA novel | 4 | V>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1329035255 CA358679256 |
4 | V>I | No |
ClinGen gnomAD |
|
rs1391523766 CA358679246 |
5 | T>A | No |
ClinGen gnomAD |
|
rs145096921 CA3128252 |
5 | T>M | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs761535352 CA3128249 |
6 | A>T | No |
ClinGen ExAC gnomAD |
|
CA358679234 rs1313191844 |
6 | A>V | No |
ClinGen TOPMed |
|
rs1464873087 CA358679211 |
9 | D>V | No |
ClinGen gnomAD |
|
rs1406571630 CA358679197 |
11 | R>* | No |
ClinGen TOPMed gnomAD |
|
CA3128248 rs776231563 |
11 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3128244 rs371889994 |
16 | C>* | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs760531293 CA3128245 |
16 | C>R | No |
ClinGen ExAC gnomAD |
|
CA3128243 rs772017371 |
18 | I>T | No |
ClinGen ExAC gnomAD |
|
rs199712307 CA3128242 |
19 | C>R | No |
ClinGen ExAC TOPMed gnomAD |
|
CA358679116 rs1457751643 |
19 | C>S | No |
ClinGen gnomAD |
|
rs1342423179 CA358679066 |
24 | K>E | No |
ClinGen TOPMed gnomAD |
|
rs1255065832 CA358679043 |
25 | D>E | No |
ClinGen gnomAD |
|
CA3128239 rs748384769 |
27 | V>G | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 28 | T>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs755359985 CA3128237 |
29 | I>M | No |
ClinGen ExAC TOPMed gnomAD |
|
rs368410573 CA3128238 |
29 | I>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA358678970 rs1394129939 |
33 | H>Y | No |
ClinGen gnomAD |
|
CA358678897 rs780661423 |
39 | C>* | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1194643258 CA358678902 |
39 | C>Y | No |
ClinGen TOPMed |
|
CA110436414 rs1008476577 |
40 | I>V | No |
ClinGen TOPMed |
|
CA358678878 rs1172246905 |
41 | I>T | No |
ClinGen gnomAD |
|
CA3128233 rs758978315 |
42 | M>V | No |
ClinGen ExAC TOPMed gnomAD |
|
rs139456338 CA110436409 |
44 | W>* | No |
ClinGen ESP |
|
rs749840760 CA3128232 |
45 | K>N | No |
ClinGen ExAC gnomAD |
|
CA358678824 rs1439618829 |
46 | D>H | No |
ClinGen gnomAD |
|
rs1396729795 CA358678820 |
46 | D>V | No |
ClinGen TOPMed |
|
rs1185752063 CA358678812 |
47 | L>V | No |
ClinGen TOPMed gnomAD |
|
CA358678801 rs1385896275 |
48 | H>R | No |
ClinGen TOPMed |
|
rs1295606054 CA358678802 |
48 | H>Y | No |
ClinGen gnomAD |
|
CA3128230 rs756776222 |
49 | D>G | No |
ClinGen ExAC gnomAD |
|
CA358678775 rs1560886855 |
50 | S>T | No |
ClinGen Ensembl |
|
rs1254996663 CA358678769 |
51 | F>L | No |
ClinGen TOPMed gnomAD |
|
CA110436403 COSM106387 rs142627348 |
52 | P>L | Variant assessed as Somatic; impact. skin [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated Ensembl NCI-TCGA |
CA358678746 rs1205377972 |
53 | C>Y | No |
ClinGen TOPMed gnomAD |
|
rs543810067 CA3128229 |
54 | P>A | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs543810067 CA3128228 |
54 | P>S | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs1028492535 CA110436397 |
56 | C>S | No |
ClinGen TOPMed |
|
rs1310858439 CA358678701 |
57 | H>R | No |
ClinGen TOPMed |
|
CA358678704 rs1238874561 |
57 | H>Y | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
rs775293768 CA3128226 |
61 | P>T | No |
ClinGen ExAC gnomAD |
|
CA3128225 rs767375704 |
62 | E>Q | No |
ClinGen ExAC gnomAD |
|
CA358678658 rs1232925052 |
63 | R>G | No |
ClinGen TOPMed |
|
CA358678648 rs1318786143 |
64 | K>T | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
rs1382964059 CA358678638 |
65 | F>C | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
CA3128224 rs759530654 |
66 | I>K | No |
ClinGen ExAC gnomAD |
|
rs576558446 CA3128223 |
66 | I>M | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA110436393 rs995242022 |
66 | I>V | No |
ClinGen TOPMed gnomAD |
|
rs1388101558 CA358678624 |
67 | S>R | No |
ClinGen gnomAD |
|
rs201546190 CA3128222 |
69 | P>L | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs543109171 CA110436387 |
70 | Q>* | No |
ClinGen 1000Genomes |
|
CA358678603 rs1318802954 |
71 | L>M | No |
ClinGen TOPMed gnomAD |
|
rs748213891 CA3128221 |
71 | L>Q | No |
ClinGen ExAC gnomAD |
|
CA3128220 rs572594143 |
73 | S>N | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs1368232414 CA358678583 |
74 | L>S | No |
ClinGen gnomAD |
|
rs769024115 CA3128219 |
75 | T>I | No |
ClinGen ExAC gnomAD |
|
rs1260661361 CA358678557 |
78 | A>S | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
CA358678541 rs1464045147 |
80 | Q>R | No |
ClinGen TOPMed |
|
rs780573657 CA3128216 |
81 | L>F | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3128214 rs746373324 |
82 | Q>R | No |
ClinGen ExAC TOPMed gnomAD |
|
CA358678508 rs1355608392 |
85 | S>N | No |
ClinGen gnomAD |
|
TCGA novel | 86 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs779356769 CA3128213 |
87 | K>N | No |
ClinGen ExAC gnomAD |
|
CA3128212 rs756762691 |
88 | R>K | No |
ClinGen ExAC TOPMed gnomAD |
|
rs756762691 CA358678486 |
88 | R>T | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1560886727 CA358678465 |
91 | Q>* | No |
ClinGen Ensembl |
|
CA358678460 rs1462005328 |
91 | Q>H | No |
ClinGen TOPMed |
|
TCGA novel | 92 | E>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1579148351 CA358678455 |
92 | E>G | No |
ClinGen Ensembl |
|
CA358678458 rs1399434391 |
92 | E>Q | No |
ClinGen gnomAD |
|
TCGA novel | 93 | E>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3128208 rs777362298 |
93 | E>K | No |
ClinGen ExAC gnomAD |
|
CA3128207 rs755764909 |
95 | H>Y | No |
ClinGen ExAC TOPMed gnomAD |
|
rs752427274 CA3128206 |
98 | K>E | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1479013470 CA358678396 |
100 | H>R | No |
ClinGen gnomAD |
|
rs767325944 CA3128204 |
101 | N>D | No |
ClinGen ExAC TOPMed gnomAD |
|
CA358678389 rs1265815293 |
101 | N>S | No |
ClinGen TOPMed |
|
CA358678391 rs767325944 |
101 | N>Y | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1480589163 CA358678341 |
108 | C>R | No |
ClinGen TOPMed gnomAD |
|
rs759316233 CA3128202 |
108 | C>Y | No |
ClinGen ExAC |
|
rs751482248 CA3128201 |
109 | Q>E | No |
ClinGen ExAC TOPMed gnomAD |
|
CA358678317 rs1450951490 |
111 | D>G | No |
ClinGen gnomAD |
|
CA3128200 rs554160561 |
111 | D>Y | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA358678313 rs1197264018 |
112 | L>V | No |
ClinGen gnomAD |
|
CA3128198 rs539032260 |
113 | E>Q | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs200764159 CA3128197 |
114 | L>F | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
TCGA novel | 114 | L>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs768933913 COSM131330 CA3128196 |
116 | C>Y | liver [Cosmic] | No |
ClinGen cosmic curated ExAC TOPMed gnomAD |
CA3128195 rs760992307 |
117 | P>S | No |
ClinGen ExAC TOPMed gnomAD |
|
rs775916827 CA3128194 |
118 | R>T | No |
ClinGen ExAC gnomAD |
|
CA3128193 rs772484077 |
121 | L>F | No |
ClinGen ExAC gnomAD |
|
CA358678199 rs1467468773 |
123 | T>I | No |
ClinGen gnomAD |
|
rs779455119 CA3128191 |
124 | D>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA358678186 rs1170467439 |
125 | H>D | No |
ClinGen TOPMed gnomAD |
|
rs1170467439 CA358678187 |
125 | H>N | No |
ClinGen TOPMed gnomAD |
|
CA3128190 rs537775495 |
128 | H>R | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs1469995158 CA358678144 |
128 | H>Y | No |
ClinGen gnomAD |
|
CA358678091 rs1457892985 |
132 | P>R | No |
ClinGen TOPMed |
|
rs748726538 CA3128188 |
132 | P>S | No |
ClinGen ExAC TOPMed gnomAD |
|
rs748726538 CA358678095 |
132 | P>T | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1299237649 CA358678082 |
133 | I>T | No |
ClinGen TOPMed |
|
rs1477412097 CA358678067 |
134 | K>N | No |
ClinGen gnomAD |
|
rs777274643 CA3128187 |
136 | A>P | No |
ClinGen ExAC TOPMed gnomAD |
|
CA358678050 rs777274643 |
136 | A>T | No |
ClinGen ExAC TOPMed gnomAD |
|
CA358678029 rs1180454135 |
137 | A>V | No |
ClinGen gnomAD |
|
rs752341472 CA3128185 |
138 | S>F | No |
ClinGen ExAC gnomAD |
|
CA358678013 rs1233384081 |
139 | Y>C | No |
ClinGen TOPMed |
|
CA358677966 rs1324516283 |
143 | K>E | No |
ClinGen gnomAD |
|
rs780747642 CA3128184 |
143 | K>I | No |
ClinGen ExAC TOPMed gnomAD |
|
rs747284694 | 144 | L>T | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No | NCI-TCGA |
CA3128181 rs1553979445 |
145 | E>K | No |
ClinGen Ensembl |
|
TCGA novel | 146 | E>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3128179 rs751331518 |
148 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1388132023 CA358677892 |
149 | A>T | No |
ClinGen TOPMed gnomAD |
|
CA3128178 rs766301795 |
149 | A>V | No |
ClinGen ExAC gnomAD |
|
rs762989181 CA3128177 |
150 | P>L | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
rs764256234 CA3128175 |
151 | W>* | No |
ClinGen ExAC gnomAD |
|
rs760908253 CA3128173 |
158 | I>L | No |
ClinGen ExAC gnomAD |
|
rs760908253 CA358677784 |
158 | I>V | No |
ClinGen ExAC gnomAD |
|
rs907459925 CA110436320 |
160 | K>N | No |
ClinGen TOPMed gnomAD |
|
rs199540291 CA358677738 |
161 | V>A | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs199540291 CA3128172 |
161 | V>D | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA3128171 rs199540291 |
161 | V>G | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs548790230 CA3128170 |
162 | I>V | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA3128169 rs533598241 |
163 | T>I | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA358677669 rs1428227660 |
166 | T>I | No |
ClinGen TOPMed |
|
rs771409006 CA3128168 |
167 | R>G | No |
ClinGen ExAC gnomAD |
|
CA3128167 rs749777767 |
167 | R>K | No |
ClinGen ExAC gnomAD |
|
rs778315295 CA3128166 |
167 | R>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3128165 rs566241270 |
168 | K>R | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA3128164 rs747704179 |
169 | S>* | No |
ClinGen ExAC TOPMed gnomAD |
|
CA358677646 rs1415092502 |
169 | S>P | No |
ClinGen TOPMed |
|
CA358677616 rs1227195347 |
173 | K>E | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
CA358674590 CA358674588 rs1431721520 |
176 | M>I | No |
ClinGen TOPMed |
|
rs1254625430 CA358674594 |
176 | M>L | No |
ClinGen TOPMed |
|
rs1579138908 CA358674577 |
178 | S>A | No |
ClinGen Ensembl |
|
rs1165144998 CA358674569 |
179 | P>R | No |
ClinGen gnomAD |
|
rs1198419897 CA358674566 |
180 | S>P | No |
ClinGen TOPMed |
|
CA358674543 rs1364468369 |
183 | R>S | No |
ClinGen TOPMed |
|
rs1402059291 CA358674537 |
185 | E>K | No |
ClinGen gnomAD |
|
CA358674518 rs1416169674 |
187 | S>N | No |
ClinGen gnomAD |
|
rs1186051318 CA358674511 |
188 | C>G | No |
ClinGen gnomAD |
|
CA358674503 rs1475026585 |
189 | T>A | No |
ClinGen gnomAD |
|
CA110432982 rs369400329 |
190 | I>N | No |
ClinGen Ensembl |
|
CA110432978 rs540495146 |
191 | S>L | No |
ClinGen TOPMed gnomAD |
|
CA358674491 rs1263994314 |
191 | S>P | No |
ClinGen gnomAD |
|
CA110432980 rs540495146 |
191 | S>W | No |
ClinGen TOPMed gnomAD |
|
rs1384783436 CA358674481 |
193 | H>D | No |
ClinGen TOPMed |
|
rs1384783436 CA358674482 |
193 | H>N | No |
ClinGen TOPMed |
|
rs1396132104 CA358674473 |
194 | F>L | No |
ClinGen gnomAD |
|
CA358674462 rs1579138845 |
195 | N>T | No |
ClinGen Ensembl |
|
rs111408210 CA3128027 |
197 | R>C | No |
ClinGen ExAC TOPMed gnomAD |
|
CA110432973 rs934816839 |
197 | R>H | No |
ClinGen TOPMed |
|
rs1323898838 CA358674437 |
199 | P>L | No |
ClinGen gnomAD |
|
rs926000425 CA358674416 |
203 | D>N | No |
ClinGen TOPMed gnomAD |
|
rs1209487312 CA358674412 |
203 | D>V | No |
ClinGen TOPMed |
|
rs926000425 CA110432965 |
203 | D>Y | No |
ClinGen TOPMed gnomAD |
|
rs947646064 CA110432963 |
204 | S>C | No |
ClinGen TOPMed gnomAD |
|
CA358674399 rs1318234793 |
205 | S>F | No |
ClinGen TOPMed gnomAD |
|
CA358674382 rs1397604911 |
208 | G>A | No |
ClinGen gnomAD |
No associated diseases with Q5EBN2
1 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
2 GO annotations of molecular function
Name | Definition |
---|---|
ubiquitin protein ligase activity | Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S -> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an amide bond: an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate or, in the linear extension of ubiquitin chains, a peptide bond the between the C-terminal glycine and N-terminal methionine of ubiquitin residues. |
zinc ion binding | Binding to a zinc ion (Zn). |
3 GO annotations of biological process
Name | Definition |
---|---|
innate immune response | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
protein ubiquitination | The process in which one or more ubiquitin groups are added to a protein. |
regulation of gene expression | Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
49 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q5E9G4 | TRIM10 | Tripartite motif-containing protein 10 | Bos taurus (Bovine) | PR |
Q2T9Z0 | TRIM17 | E3 ubiquitin-protein ligase TRIM17 | Bos taurus (Bovine) | PR |
E1BJS7 | TRIM71 | E3 ubiquitin-protein ligase TRIM71 | Bos taurus (Bovine) | PR |
Q7YRV4 | TRIM21 | E3 ubiquitin-protein ligase TRIM21 | Bos taurus (Bovine) | PR |
Q1PRL4 | TRIM71 | E3 ubiquitin-protein ligase TRIM71 | Gallus gallus (Chicken) | PR |
Q7YR32 | TRIM10 | Tripartite motif-containing protein 10 | Pan troglodytes (Chimpanzee) | PR |
Q9BTV5 | FSD1 | Fibronectin type III and SPRY domain-containing protein 1 | Homo sapiens (Human) | PR |
Q9UJV3 | MID2 | Probable E3 ubiquitin-protein ligase MID2 | Homo sapiens (Human) | PR |
P29590 | PML | Protein PML | Homo sapiens (Human) | PR |
Q9NQ86 | TRIM36 | E3 ubiquitin-protein ligase TRIM36 | Homo sapiens (Human) | PR |
Q86UV6 | TRIM74 | Tripartite motif-containing protein 74 | Homo sapiens (Human) | PR |
Q2Q1W2 | TRIM71 | E3 ubiquitin-protein ligase TRIM71 | Homo sapiens (Human) | PR |
Q9BXM9 | FSD1L | FSD1-like protein | Homo sapiens (Human) | PR |
Q86UV7 | TRIM73 | Tripartite motif-containing protein 73 | Homo sapiens (Human) | PR |
Q86XT4 | TRIM50 | E3 ubiquitin-protein ligase TRIM50 | Homo sapiens (Human) | PR |
Q8N9V2 | TRIML1 | Probable E3 ubiquitin-protein ligase TRIML1 | Homo sapiens (Human) | PR |
Q9BZY9 | TRIM31 | E3 ubiquitin-protein ligase TRIM31 | Homo sapiens (Human) | PR |
Q9H2S5 | RNF39 | RING finger protein 39 | Homo sapiens (Human) | PR |
Q6ZMU5 | TRIM72 | Tripartite motif-containing protein 72 | Homo sapiens (Human) | PR |
Q9UPQ4 | TRIM35 | E3 ubiquitin-protein ligase TRIM35 | Homo sapiens (Human) | PR |
Q9C029 | TRIM7 | E3 ubiquitin-protein ligase TRIM7 | Homo sapiens (Human) | PR |
O15553 | MEFV | Pyrin | Homo sapiens (Human) | SS |
A6NCK2 | TRIM43B | Tripartite motif-containing protein 43B | Homo sapiens (Human) | PR |
P19474 | TRIM21 | E3 ubiquitin-protein ligase TRIM21 | Homo sapiens (Human) | PR |
Q14142 | TRIM14 | Tripartite motif-containing protein 14 | Homo sapiens (Human) | PR |
A6NK02 | TRIM75 | Tripartite motif-containing protein 75 | Homo sapiens (Human) | PR |
Q9WUH5 | Trim10 | Tripartite motif-containing protein 10 | Mus musculus (Mouse) | PR |
Q8BZT2 | Sh3rf2 | E3 ubiquitin-protein ligase SH3RF2 | Mus musculus (Mouse) | PR |
Q7TPM3 | Trim17 | E3 ubiquitin-protein ligase TRIM17 | Mus musculus (Mouse) | PR |
Q1XH17 | Trim72 | Tripartite motif-containing protein 72 | Mus musculus (Mouse) | PR |
Q60953 | Pml | Protein PML | Mus musculus (Mouse) | PR |
Q9JJ26 | Mefv | Pyrin | Mus musculus (Mouse) | SS |
Q99PQ1 | Trim12a | Tripartite motif-containing protein 12A | Mus musculus (Mouse) | PR |
Q61510 | Trim25 | E3 ubiquitin/ISG15 ligase TRIM25 | Mus musculus (Mouse) | PR |
Q810I2 | Trim50 | E3 ubiquitin-protein ligase TRIM50 | Mus musculus (Mouse) | PR |
Q1PSW8 | Trim71 | E3 ubiquitin-protein ligase TRIM71 | Mus musculus (Mouse) | PR |
Q3TL54 | Trim43a | Tripartite motif-containing protein 43A | Mus musculus (Mouse) | PR |
P86449 | Trim43c | Tripartite motif-containing protein 43C | Mus musculus (Mouse) | PR |
O77666 | TRIM26 | Tripartite motif-containing protein 26 | Sus scrofa (Pig) | PR |
O19085 | TRIM10 | Tripartite motif-containing protein 10 | Sus scrofa (Pig) | PR |
Q865W2 | TRIM50 | E3 ubiquitin-protein ligase TRIM50 | Sus scrofa (Pig) | PR |
Q920M2 | Rnf39 | RING finger protein 39 | Rattus norvegicus (Rat) | PR |
Q9JJ25 | Mefv | Pyrin | Rattus norvegicus (Rat) | SS |
A0JPQ4 | Trim72 | Tripartite motif-containing protein 72 | Rattus norvegicus (Rat) | PR |
Q810I1 | Trim50 | E3 ubiquitin-protein ligase TRIM50 | Rattus norvegicus (Rat) | PR |
D3ZVM4 | Trim71 | E3 ubiquitin-protein ligase TRIM71 | Rattus norvegicus (Rat) | PR |
F6QEU4 | trim71 | E3 ubiquitin-protein ligase TRIM71 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | PR |
Q640S6 | trim72 | Tripartite motif-containing protein 72 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | PR |
E7FAM5 | trim71 | E3 ubiquitin-protein ligase TRIM71 | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MEFVTALADL | RAEASCPICL | DYLKDPVTIS | CGHNFCLSCI | IMSWKDLHDS | FPCPFCHFCC |
70 | 80 | 90 | 100 | 110 | 120 |
PERKFISNPQ | LGSLTEIAKQ | LQIRSKKRKR | QEEKHVCKKH | NQVLTFFCQK | DLELLCPRCS |
130 | 140 | 150 | 160 | 170 | 180 |
LSTDHQHHCV | WPIKKAASYH | RKKLEEYNAP | WKERVELIEK | VITMQTRKSL | ELKKKMESPS |
190 | 200 | ||||
VTRLECSCTI | SAHFNLRLPG | SSDSSASGS |